Intervention not reported
28‐day all‐cause mortality · hospitalised adults with COVID‐19 (moderate to severe disease)
The intervention probably leads to lower 28‐day all‐cause mortality (moderate certainty).
1 finding from 1 review
Intervention not reported
Quality of life up to longest · non‐hospitalised adults with mild COVID‐19
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Thrombotic events up to day 45 · non‐hospitalised adults with mild COVID‐19
The intervention showed no clear difference in thrombotic events up to day 45 (low certainty).
1 finding from 1 review
Intervention not reported
Adverse events during study treatment · non‐hospitalised adults with mild COVID‐19
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Serious adverse events up to day 45 · non‐hospitalised adults with mild COVID‐19
The intervention showed no clear difference in serious adverse events up to day 45 (low certainty).
1 finding from 1 review
Intervention not reported
Major bleeding events up to longest · non‐hospitalised adults with mild COVID‐19
1 finding from 1 review
Intervention not reported
Worsening up to day 28: participants with new need for invasive mechanical ventilation or death · hospitalised adults with COVID‐19 (moderate to severe disease)
The intervention showed no clear difference in worsening up to day 28: participants with new need for invasive… (moderate certainty).
1 finding from 1 review
Intervention not reported
Improvement up to day 28: participants discharged alive · hospitalised adults with COVID‐19 (moderate to severe disease)
The intervention showed no clear difference in improvement up to day 28: participants discharged alive (moderate certainty).
1 finding from 1 review
Intervention not reported
Thrombotic events at longest · hospitalised adults with COVID‐19 (moderate to severe disease)
The intervention showed no clear difference in thrombotic events at longest (moderate certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events at longest · hospitalised adults with COVID‐19 (moderate to severe disease)
The intervention showed no clear difference in serious adverse events at longest (low certainty).
1 finding from 1 review
Intervention not reported
Adverse events during study treatment · hospitalised adults with COVID‐19 (moderate to severe disease)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Major bleeding events at longest · hospitalised adults with COVID‐19 (moderate to severe disease)
The intervention probably leads to higher major bleeding events at longest (moderate certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality at day 45 · non‐hospitalised adults with mild COVID‐19
The intervention showed no clear difference in all‐cause mortality at day 45 (low certainty).
1 finding from 1 review
Intervention not reported
Admission to hospital or death up to day 45 · non‐hospitalised adults with mild COVID‐19
It is very uncertain whether the intervention changes admission to hospital or death up to day 45 (very low certainty).
1 finding from 1 review